Related Experiment Video
Updated: Mar 8, 2026

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Clinical value of the systemic immune-inflammation index in patients with Crohn disease
Jing Yan1, Rongkun Wang2, Xiaojing Zhang3
1Department of Gastroenterology, Peking University People's Hospital Qingdao Hospital, Women and Children's Hospital, Qingdao University, Qingdao, Shandong, China.
Abstract:
The systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) are emerging biomarkers that reflect the immunological and inflammatory states of an organism. The calculation formula for SII is neutrophil (N) * platelet (P)/lymphocyte (L). However, the clinical relevance of SII in Crohn disease (CD) has not yet been explored. The primary aim of this study was to investigate the associations between SII, PLR, and NLR and CD, and to compare their respective potentials in evaluating disease activity. Our retrospective study included 119 CD patients and 121 sex- and age-matched healthy individuals who visited our hospital between February 2014 and February 2023. Clinical data and laboratory indices for all participants were retrieved from the hospital's medical record system. Disease activity in CD patients was assessed and quantified using the CD activity index. The SII was significantly higher in CD patients in comparison with healthy individuals (all P <.05). Among CD patients, males exhibited higher SII values than females, and patients with a low body mass index had higher SII values than those with a high body mass index (P <.05). SII, PLR, and NLR demonstrated numerically stronger positive correlations with CD Endoscopic Index of Severity (R = 0.298-0.370, P <.01) and Simple Endoscopic Score for CD (R = 0.309-0.382, P <.01) compared to CRP (R = 0.252, P = .009; R = 0.295, P = .002). Furthermore, multiple linear regression analysis revealed an independent association between penetrating disease and SII (beta = 0.455, t = 5.250, P <.001). The SII exhibited superior diagnostic performance for penetrating CD compared to PLR, NLR and CRP, demonstrating an area under the receiver operating characteristic (ROC) curve of 0.710. The cutoff value of SII was determined to be 1745.85, with a sensitivity of 0.615 and specificity of 0.783. We demonstrated that SII levels were significantly higher in CD patients compared to healthy individuals and were positively correlated with disease activity in CD. Furthermore, SII showed superior diagnostic performance in ruling out non CD compared to PLR, NLR and CRP.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

